Suitability of infiltrative lobular breast carcinoma for anti‐human epidermal growth factor receptor 2 treatment after the ASCO/CAP and 2009 St Gallen International Expert Consensus meeting
Authors:
- 17 December 2010
- journal article
- Published by Wiley in Histopathology
- Vol. 57 (6) , 935-940
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009Annals of Oncology, 2009
- Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray‐based CGH analysisThe Journal of Pathology, 2009
- Lack of prognostic significance of “classic” lobular breast carcinoma: a matched, single institution seriesBreast Cancer Research and Treatment, 2008
- HER-2/neu Assessment in Breast Cancer Using the Original FDA and New ASCO/CAP Guideline RecommendationsAmerican Journal of Clinical Pathology, 2008
- HER2Status and Benefit from Adjuvant Trastuzumab in Breast CancerNew England Journal of Medicine, 2008
- Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entityThe Journal of Pathology, 2005